Nippon India Pharma Fund Overview
Category Pharma Fund
BMSMONEY Rank -
BMSMONEY Rating
Gro. Opt. As On: 19-11-2024
NAV ₹499.19(R) +0.92% ₹552.7(D) +0.93%
Returns 1Y 3Y 5Y 7Y 10Y
LumpSum (R) 34.98% 18.27% 27.41% 20.52% 15.01%
LumpSum (D) 36.19% 19.34% 28.56% 21.6% 16.03%
SIP (R) 8.61% 27.99% 24.46% 23.34% 18.72%
SIP (D) 9.65% 29.14% 25.59% 24.43% 19.72%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
0.79 0.42 0.72 2.15% 0.13
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
15.09% -14.68% -16.86% 0.91 10.4%
Top Pharma Fund
Fund Name Rank Rating
Icici Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
Sbi Healthcare Opportunities Fund -
Tata India Pharma & Healthcare Fund -
Dsp Healthcare Fund -
Uti Healthcare Fund -

NAV Date: 19-11-2024

Scheme Name NAV Rupee Change Percent Change
NIPPON INDIA PHARMA FUND - IDCW Option 127.1
1.1600
0.9200%
NIPPON INDIA PHARMA FUND - DIRECT Plan - IDCW Option 177.14
1.6200
0.9300%
Nippon India Pharma Fund-Growth Plan-Growth Option 499.19
4.5700
0.9200%
Nippon India Pharma Fund-Growth Plan-Bonus Option 499.19
4.5700
0.9200%
Nippon India Pharma Fund - Direct Plan Growth Plan - Bonus Option 552.7
5.0700
0.9300%
Nippon India Pharma Fund - Direct Plan Growth Plan - Growth Option 552.7
5.0700
0.9300%

Review Date: 19-11-2024

A review of the different performance parameters of the fund is as follows:
  1. Returns: It reflects the surge in the investment's value throughout the investment period, communicated as a percentage or a specific monetary sum. Our analysis encompassed six return parameters of this fund. We have organized the return parameters into three performance groups for evaluation: the top 25%, parameters that rank below the top 25% but above average, and parameters that are below average. Below, you'll find a breakdown of how each parameter has performed.
    1. Top 25%: The fund does not have any return parameter in the top 25% in the category.
    2. Above Average Below the Top 25%: The fund does not have any return parameter which is above average but below the top 25%.
    3. Below Average: Nippon India Pharma Fund has six return parameters that are below average in the category, which are listed below:
      • 1Y Return %
      • 5Y Return %
      • 3Y Return %
      • 6M Return %
      • 3M Return %
      • 1M Return %
  2. Risk: Various factors can lead to the risk of either not meeting expected returns or encountering a monetary loss. For Nippon India Pharma Fund, we have analyzed two risk parameters and divided them into three groups the lowest 25%, below average but above the lowest 25%, and above average, which are described below.
    1. Lowest 25%: Nippon India Pharma Fund does not have any risk parameters in the lowest 25% of the category. It means high risk compared to other funds in the category.
    2. Below Average but Above the Lowest 25%: Nippon India Pharma Fund has two risk parameters that are below average but above the lowest 25% in the category. These are:
      • Standard Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the standard deviation, the greater the risk. The standard deviation of the fund is 15.09 %.
      • Semi-Deviation: It is a measure of the dispersion of a set of data from its mean. It is calculated as the square root of variance by determining the variation between each data point relative to the mean. The higher the semi-deviation, the greater the risk. The semi-deviation of the fund is 10.4 %.
    3. Above Average: Nippon India Pharma Fund does not have any risk parameters above average; which is a good sign.
  3. Risk Adjusted Performance Parameters: In mutual funds, risk-adjusted performance parameters are evaluation tools that gauge the returns of an investment against the risk taken. They assist investors in comparing various investments, factoring in both risk and returns. We have evaluated four risk-adjusted performance parameters of the fund.
    1. Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the top 25% of the category.
    2. Above Average Below Top 25% Risk Adjusted Performance Parameters: The fund does not have any risk-adjusted performance parameters that are in the above average but below top 25% of the category.
    3. Below Average Risk Adjusted Performance Parameters: Nippon India Pharma Fund has four risk-adjusted performance parameters of the fund that are below average in the category.
      • Sharpe Ratio: Nippon India Pharma Fund has a Sharpe Ratio of 0.79 compared to the category average of 0.85.
      • Sterling Ratio: Nippon India Pharma Fund has a Sterling Ratio of 0.72 compared to the category average of 0.78.
      • Sortino Ratio: Nippon India Pharma Fund has a Sortino Ratio of 0.42 compared to the category average of 0.47.
      • Treynor Ratio: Nippon India Pharma Fund has a Treynor Ratio of 0.13 compared to the category average of 0.14.


Not able to see in mobile!!! save the chart by clicking on camera icon.

KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -3.77
-3.29
-6.13 | -1.38 9 | 13 Average
3M Return % 0.10
1.96
-4.87 | 6.68 9 | 13 Average
6M Return % 13.94
18.30
11.91 | 24.73 11 | 13 Average
1Y Return % 34.98
42.10
34.98 | 50.25 11 | 11 Poor
3Y Return % 18.27
19.81
16.87 | 23.20 6 | 8 Average
5Y Return % 27.41
27.82
23.59 | 30.75 6 | 8 Average
7Y Return % 20.52
19.20
18.34 | 20.52 1 | 4 Very Good
10Y Return % 15.01
13.72
12.74 | 15.01 1 | 3 Very Good
15Y Return % 18.80
17.82
16.46 | 18.80 1 | 3 Very Good
1Y SIP Return % 8.61
11.42
-16.11 | 26.02 8 | 11 Average
3Y SIP Return % 27.99
29.69
26.71 | 34.29 6 | 8 Average
5Y SIP Return % 24.46
25.28
22.04 | 28.06 5 | 8 Average
7Y SIP Return % 23.34
23.52
23.02 | 24.40 2 | 4 Good
10Y SIP Return % 18.72
18.02
17.47 | 18.72 1 | 3 Very Good
15Y SIP Return % 18.15
17.28
16.21 | 18.15 1 | 3 Very Good
Standard Deviation 15.09
15.31
14.31 | 15.96 4 | 8 Good
Semi Deviation 10.40
10.45
10.03 | 10.78 3 | 8 Good
Max Drawdown % -16.86
-16.50
-18.92 | -14.27 4 | 8 Good
VaR 1 Y % -14.68
-16.74
-18.91 | -14.68 1 | 8 Very Good
Average Drawdown % -5.51
-5.03
-7.25 | -3.98 6 | 8 Average
Sharpe Ratio 0.79
0.85
0.66 | 1.10 6 | 8 Average
Sterling Ratio 0.72
0.78
0.66 | 0.96 6 | 8 Average
Sortino Ratio 0.42
0.47
0.36 | 0.59 6 | 8 Average
Jensen Alpha % 2.15
3.31
-0.30 | 7.34 6 | 8 Average
Treynor Ratio 0.13
0.14
0.11 | 0.19 6 | 8 Average
Modigliani Square Measure % 20.81
21.86
18.21 | 26.49 5 | 8 Average
Alpha % 0.42
1.69
-1.06 | 4.46 6 | 8 Average
Return data last Updated On : Nov. 19, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Benchmark Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % -3.71 -3.19 -6.01 | -1.30 9 | 13
3M Return % 0.32 2.29 -4.48 | 7.04 9 | 13
6M Return % 14.45 19.06 12.84 | 25.80 11 | 13
1Y Return % 36.19 43.86 36.19 | 52.14 11 | 11
3Y Return % 19.34 21.27 18.64 | 24.29 6 | 8
5Y Return % 28.56 29.43 25.54 | 32.68 6 | 8
7Y Return % 21.60 20.57 19.64 | 21.60 1 | 4
10Y Return % 16.03 14.87 13.86 | 16.03 1 | 3
1Y SIP Return % 9.65 12.87 -14.86 | 27.66 8 | 11
3Y SIP Return % 29.14 31.23 28.48 | 35.44 6 | 8
5Y SIP Return % 25.59 26.80 23.81 | 29.20 7 | 8
7Y SIP Return % 24.43 24.87 24.43 | 25.70 4 | 4
10Y SIP Return % 19.72 19.11 18.56 | 19.72 1 | 3
Standard Deviation 15.09 15.31 14.31 | 15.96 4 | 8
Semi Deviation 10.40 10.45 10.03 | 10.78 3 | 8
Max Drawdown % -16.86 -16.50 -18.92 | -14.27 4 | 8
VaR 1 Y % -14.68 -16.74 -18.91 | -14.68 1 | 8
Average Drawdown % -5.51 -5.03 -7.25 | -3.98 6 | 8
Sharpe Ratio 0.79 0.85 0.66 | 1.10 6 | 8
Sterling Ratio 0.72 0.78 0.66 | 0.96 6 | 8
Sortino Ratio 0.42 0.47 0.36 | 0.59 6 | 8
Jensen Alpha % 2.15 3.31 -0.30 | 7.34 6 | 8
Treynor Ratio 0.13 0.14 0.11 | 0.19 6 | 8
Modigliani Square Measure % 20.81 21.86 18.21 | 26.49 5 | 8
Alpha % 0.42 1.69 -1.06 | 4.46 6 | 8
Return data last Updated On : Nov. 19, 2024.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : Oct. 31, 2024
KPIs: Key Performance Indicators

Investment Period Regular Direct
Return % Current Value of ₹ 10000 Return % Current Value of ₹ 10000
1D 0.92 ₹ 10,092.00 0.93 ₹ 10,093.00
1W -1.38 ₹ 9,862.00 -1.36 ₹ 9,864.00
1M -3.77 ₹ 9,623.00 -3.71 ₹ 9,629.00
3M 0.10 ₹ 10,010.00 0.32 ₹ 10,032.00
6M 13.94 ₹ 11,394.00 14.45 ₹ 11,445.00
1Y 34.98 ₹ 13,498.00 36.19 ₹ 13,619.00
3Y 18.27 ₹ 16,544.00 19.34 ₹ 16,997.00
5Y 27.41 ₹ 33,570.00 28.56 ₹ 35,121.00
7Y 20.52 ₹ 36,930.00 21.60 ₹ 39,304.00
10Y 15.01 ₹ 40,496.00 16.03 ₹ 44,228.00
15Y 18.80 ₹ 132,449.00 ₹

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.

Investment Period Invested Amount Regular Direct
XIRR % Current Value of Invested Amount XIRR % Current Value of Invested Amount
1Y ₹ 12000 8.61 ₹ 12,554.53 9.65 ₹ 12,620.16
3Y ₹ 36000 27.99 ₹ 53,907.98 29.14 ₹ 54,744.19
5Y ₹ 60000 24.46 ₹ 110,017.74 25.59 ₹ 113,028.12
7Y ₹ 84000 23.34 ₹ 193,045.36 24.43 ₹ 200,651.05
10Y ₹ 120000 18.72 ₹ 321,686.16 19.72 ₹ 339,501.72
15Y ₹ 180000 18.15 ₹ 812,529.00 ₹


Date Nippon India Pharma Fund NAV Regular Growth Nippon India Pharma Fund NAV Direct Growth
19-11-2024 499.1941 552.7013
18-11-2024 494.6282 547.6326
14-11-2024 497.8625 551.1591
13-11-2024 497.4773 550.7191
12-11-2024 506.1576 560.3146
11-11-2024 509.2275 563.699
08-11-2024 514.6295 569.6367
07-11-2024 514.3662 569.3313
06-11-2024 517.2089 572.4637
05-11-2024 512.2913 567.0068
04-11-2024 511.0752 565.645
31-10-2024 514.737 569.6415
30-10-2024 506.67 560.7001
29-10-2024 507.2771 561.3582
28-10-2024 510.4544 564.8603
25-10-2024 505.8776 559.7543
24-10-2024 507.5637 561.6061
23-10-2024 506.1017 559.975
22-10-2024 511.4318 565.8585
21-10-2024 518.7774 573.9716

Fund Launch Date: 10/May/2004
Fund Category: Pharma Fund
Investment Objective: The Fund seeks to invest in pharma sector with focus on important segments of the sector viz Domestic Business, International & CRAMS and include deep value as well as high growth pharma businesses. The fund invests across market capitalization within the sector. It may suit investment horizon of around 2-3 years
Fund Description: An open ended equity scheme investing in pharma sector
Fund Benchmark: S&P BSE Healthcare TR
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.